Income Statement Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:25 2024-09-17 am EDT			5-day change	1st Jan Change
266.20 ^CHF	+0.80%		-1.00%	+8.88%

Sep. 16	Mindpeak Announces Collaboration with Roche to Enhance Cancer Diagnostics Through AI	CI
Sep. 16	Swiss Market Index Closes in Red; Roche Slips	MT

56c7af1a42e07b62946192.lVmJsV9sXxxiz5PHMnE-5-BfJQlOqAE6hKjbRzpDXhw.5hP8hgUKBWhWusCDHyJOyrE-diQI5VEO8-LqdVAyCWrKYdboDBwHfguO5A

Published financial data: ROCHE HOLDING AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	63.75B	60.34B	65.85B	66.43B	58.72B
Other Revenues, Total	-	-	-	-	1.72B
Total Revenues	63.75B	60.34B	65.85B	66.43B	60.44B
Cost of Goods Sold, Total	17.38B	15.86B	19.36B	18.6B	15.6B
Gross Profit	46.37B	44.48B	46.49B	47.83B	44.84B
Selling General & Admin Expenses, Total	13.75B	11.95B	11.98B	12.05B	13.49B
R&D Expenses	11.92B	12.57B	14.02B	14.4B	13.54B
Other Operating Expenses	227M	265M	238M	192M	34M
Other Operating Expenses, Total	25.9B	24.78B	26.24B	26.64B	27.06B
Operating Income	20.46B	19.7B	20.25B	21.19B	17.78B
Interest Expense, Total	-620M	-438M	-342M	-608M	-828M
Interest And Investment Income	100M	16M	-	40M	195M
Net Interest Expenses	-520M	-422M	-342M	-568M	-633M
Income (Loss) On Equity Invest.	-15M	-1M	-2M	-41M	-32M
Currency Exchange Gains (Loss)	-205M	-206M	-232M	-278M	-243M
Other Non Operating Income (Expenses)	-24M	-5M	3M	-90M	-14M
EBT, Excl. Unusual Items	19.7B	19.06B	19.68B	20.21B	16.86B
Restructuring Charges	-1.25B	-909M	-1.36B	-969M	-2.04B
Merger & Related Restructuring Charges	43M	-9M	-55M	38M	-25M
Impairment of Goodwill	-779M	-247M	-	-	-591M
Gain (Loss) On Sale Of Investments	189M	171M	-89M	-85M	5M
Gain (Loss) On Sale Of Assets	-	-	-	-	569M
Asset Writedown	-1.22B	-435M	-634M	-2.87B	-637M
Legal Settlements	-	345M	-122M	45M	172M
Other Unusual Items	-73M	-14M	-20M	-43M	-233M
EBT, Incl. Unusual Items	16.61B	17.96B	17.4B	16.33B	14.08B
Income Tax Expense	2.51B	2.9B	2.46B	2.8B	1.72B
Earnings From Continuing Operations	14.11B	15.07B	14.94B	13.53B	12.36B
Net Income to Company	14.11B	15.07B	14.94B	13.53B	12.36B
Minority Interest	-611M	-773M	-1B	-1.11B	-860M
Net Income - (IS)	13.5B	14.3B	13.93B	12.42B	11.5B
Net Income to Common Incl Extra Items	13.5B	14.3B	13.93B	12.42B	11.5B
Net Income to Common Excl. Extra Items	13.5B	14.3B	13.93B	12.42B	11.5B
Per Share Items
Net EPS - Basic	15.77	16.72	16.39	15.53	14.39
Basic EPS - Continuing Operations	15.77	16.72	16.39	15.53	14.39
Basic Weighted Average Shares Outstanding	856M	855M	850M	800M	799M
Net EPS - Diluted	15.62	16.52	16.2	15.37	14.31
Diluted EPS - Continuing Operations	15.62	16.52	16.2	15.37	14.31
Diluted Weighted Average Shares Outstanding	864M	865M	860M	808M	804M
Normalized Basic EPS	13.67	13.03	13.29	14.4	12.11
Normalized Diluted EPS	13.54	12.88	13.13	14.26	12.03
Dividend Per Share	9	9.1	9.3	9.5	9.6
Payout Ratio	55.19	53.86	55.8	59.95	66.01
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	24.41B	23.9B	24.33B	24.69B	20.92B
EBITA	22B	21.45B	21.81B	22.12B	18.5B
EBIT	20.46B	19.7B	20.25B	21.19B	17.78B
EBITDAR	24.53B	23.99B	24.42B	24.78B	21B
Total Revenues (As Reported)	63.75B	60.34B	65.85B	66.43B	60.44B
Effective Tax Rate - (Ratio)	15.08	16.13	14.16	17.12	12.22
Total Current Taxes	3.68B	3.51B	2.62B	4.45B	2.83B
Total Deferred Taxes	-1.18B	-610M	-156M	-1.66B	-1.11B
Normalized Net Income	11.7B	11.14B	11.3B	11.52B	9.68B
Interest on Long-Term Debt	30M	27M	24M	20M	31M
Non-Cash Pension Expense	129M	77M	23M	45M	123M
Supplemental Operating Expense Items
Selling and Marketing Expenses	10.55B	9.39B	9.48B	9.58B	-
General and Administrative Expenses	3.06B	2.46B	2.42B	2.39B	-
Research And Development Expense From Footnotes	12.77B	13.01B	14.8B	16.02B	14.2B
Net Rental Expense, Total	122M	94M	87M	87M	82M
Imputed Operating Lease Interest Expense	35.21M	21.25M	9.92M	14.28M	18.88M
Imputed Operating Lease Depreciation	86.79M	72.75M	77.08M	72.72M	63.12M
Stock-Based Comp., COGS (Total)	103M	110M	106M	106M	86M
Stock-Based Comp., R&D Exp. (Total)	233M	300M	277M	330M	385M
Stock-Based Comp., S&M Exp. (Total)	136M	151M	140M	155M	-
Stock-Based Comp., G&A Exp. (Total)	125M	152M	140M	147M	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	359M
Total Stock-Based Compensation	597M	713M	663M	738M	830M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	6.08B	5.73B	6.85B	4.99B	5.38B
Short Term Investments	5.77B	6.6B	6.18B	4.78B	5.13B
Trading Asset Securities, Total	21M	20M	4M	1M	2M
Total Cash And Short Term Investments	11.87B	12.34B	13.03B	9.77B	10.51B
Accounts Receivable, Total	10.87B	10.54B	11.35B	12.21B	11.55B
Other Receivables	1.05B	1.16B	1.23B	1.43B	1.32B
Notes Receivable	51M	-	45M	33M	55M
Total Receivables	11.96B	11.7B	12.63B	13.67B	12.92B
Inventory	6.06B	7.19B	7.72B	8.6B	7.75B
Prepaid Expenses	795M	1.15B	1.87B	1.2B	1.14B
Restricted Cash	-	-	23M	198M	61M
Other Current Assets, Total	574M	553M	359M	376M	1.06B
Total Current Assets	31.25B	32.94B	35.63B	33.82B	33.45B
Gross Property Plant And Equipment	45.04B	45.66B	48.2B	49.41B	46.2B
Accumulated Depreciation	-21.72B	-22.39B	-23.79B	-25.2B	-23.26B
Net Property Plant And Equipment	23.32B	23.27B	24.41B	24.21B	22.94B
Long-term Investments	739M	1.28B	1.07B	971M	789M
Goodwill	12.46B	9.25B	10.81B	10.82B	9.39B
Other Intangibles, Total	8.36B	12.02B	12.12B	9.68B	14.83B
Accounts Receivable Long-Term	38M	37M	36M	26M	19M
Loans Receivable Long-Term	8M	8M	7M	7M	7M
Deferred Tax Assets Long-Term	5.21B	5.46B	5.58B	6.43B	6.88B
Other Long-Term Assets, Total	1.71B	1.88B	2.66B	2.19B	2.17B
Total Assets	83.09B	86.14B	92.32B	88.15B	90.47B
Liabilities
Accounts Payable, Total	3.39B	3.32B	4.12B	4.13B	3.78B
Accrued Expenses, Total	11.28B	7.87B	9.11B	12.25B	11.43B
Short-term Borrowings	1.41B	1.58B	500M	1.76B	848M
Current Portion of Long-Term Debt	289M	2.42B	14.62B	2.36B	3.62B
Current Portion of Leases	340M	319M	329M	302M	291M
Current Income Taxes Payable	3.84B	3.68B	3B	3.19B	2.26B
Unearned Revenue Current, Total	487M	439M	560M	601M	614M
Other Current Liabilities	3.09B	5.78B	6.18B	2.65B	1.98B
Total Current Liabilities	24.12B	25.4B	38.42B	27.24B	24.82B
Long-Term Debt	12.67B	10.22B	16.08B	21.39B	24.81B
Long-Term Leases	879M	876M	1.02B	891M	1.28B
Unearned Revenue Non Current	172M	156M	246M	254M	227M
Pension & Other Post Retirement Benefits	7.48B	7.83B	6.1B	4.56B	4.38B
Deferred Tax Liability Non Current	298M	353M	628M	645M	593M
Other Non Current Liabilities	1.61B	1.53B	1.48B	1.16B	1.09B
Total Liabilities	47.22B	46.36B	63.97B	56.14B	57.2B
Common Stock, Total	160M	160M	160M	107M	107M
Retained Earnings	40.52B	45.57B	34.16B	38.94B	42.35B
Comprehensive Income and Other	-7.94B	-9.39B	-9.83B	-11.05B	-13.14B
Total Common Equity	32.75B	36.34B	24.49B	27.99B	29.32B
Minority Interest	3.12B	3.43B	3.86B	4.02B	3.95B
Total Equity	35.87B	39.77B	28.34B	32.02B	33.26B
Total Liabilities And Equity	83.09B	86.14B	92.32B	88.15B	90.47B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	852M	853M	800M	799M	797M
ECS Total Common Shares Outstanding	852M	853M	800M	799M	797M
Book Value / Share	38.43	42.6	30.6	35.03	36.77
Tangible Book Value	11.93B	15.08B	1.56B	7.49B	5.1B
Tangible Book Value Per Share	14.01	17.67	1.95	9.37	6.39
Total Debt	15.58B	15.41B	32.55B	26.7B	30.85B
Net Debt	3.72B	3.07B	19.52B	16.93B	20.34B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.75B	6.16B	4B	1.59B	1.94B
Debt Equivalent Oper. Leases	976M	752M	696M	696M	656M
Minority Interest, Total (Incl. Fin. Div)	3.12B	3.43B	3.86B	4.02B	3.95B
Equity Method Investments, Total	2M	2M	331M	300M	242M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.3B	1.35B	1.55B	1.95B	1.7B
Inventories - Work In Process, Total	4.06B	4.46B	5.84B	6.39B	5.62B
Inventories - Finished Goods, Total	1.43B	1.96B	1.2B	1.14B	1.18B
Land - (BS)	1.43B	1.35B	1.32B	1.25B	1.11B
Buildings, Total	17.35B	17.46B	18.18B	19.81B	17.93B
Machinery, Total	15.69B	15.62B	16.36B	16.78B	14.36B
Full Time Employees	97.74K	101K	101K	104K	104K
Assets on Operating Lease - Gross	5.5B	5.51B	5.64B	5.72B	5.56B
Assets on Operating Lease - Accumulated Depreciation	-3.7B	-3.83B	-4.01B	-4.16B	-3.98B
Accumulated Allowance for Doubtful Accounts (Supple)	532M	515M	538M	490M	440M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	13.5B	14.3B	13.93B	12.42B	11.5B
Depreciation & Amortization - CF	2.76B	2.81B	2.89B	2.91B	2.75B
Amortization of Goodwill and Intangible Assets - (CF)	1.53B	1.75B	1.56B	938M	716M
Depreciation & Amortization, Total	4.29B	4.56B	4.44B	3.84B	3.46B
Amortization of Deferred Charges, Total - (CF)	12M	9M	8M	4M	8M
(Gain) Loss From Sale Of Asset	-490M	-239M	-496M	-612M	-558M
(Gain) Loss on Sale of Investments - (CF)	-189M	-171M	89M	85M	-5M
Asset Writedown & Restructuring Costs	2.73B	1.15B	1.45B	2.89B	2.23B
(Income) Loss On Equity Investments - (CF)	15M	1M	2M	41M	32M
Stock-Based Compensation (CF)	597M	713M	663M	738M	830M
Provision and Write-off of Bad Debts	33M	54M	44M	3M	6M
Other Operating Activities, Total	1.74B	258M	1.84B	1.42B	-305M
Change in Other Net Operating Assets	149M	-2.06B	-994M	-2.42B	-1.11B
Cash from Operations	22.38B	18.57B	20.98B	18.42B	16.1B
Capital Expenditure	-3.5B	-3.53B	-3.69B	-3.45B	-3.74B
Sale of Property, Plant, and Equipment	71M	70M	61M	82M	173M
Cash Acquisitions	-4.71B	-1.18B	-2.36B	-245M	-6.22B
Divestitures	3M	-	7M	1M	559M
Sale (Purchase) of Intangible assets	-1.39B	-3.16B	-856M	-1.1B	-907M
Investment in Marketable and Equity Securities, Total	827M	-994M	363M	1.13B	-707M
Other Investing Activities, Total	65M	-274M	-73M	51M	201M
Cash from Investing	-8.63B	-9.07B	-6.55B	-3.54B	-10.64B
Short Term Debt Issued, Total	858M	318M	-	1.29B	-
Long-Term Debt Issued, Total	153M	341M	20.31B	8.44B	8.34B
Total Debt Issued	1.01B	659M	20.31B	9.74B	8.34B
Short Term Debt Repaid, Total	-	-	-1.13B	-	-806M
Long-Term Debt Repaid, Total	-5.79B	-369M	-2.83B	-15.84B	-2.09B
Total Debt Repaid	-5.79B	-369M	-3.96B	-15.84B	-2.9B
Issuance of Common Stock	87M	37M	-	-	-
Repurchase of Common Stock	-1.01B	-2.14B	-20.4B	-1.26B	-1.14B
Common Dividends Paid	-7.45B	-7.7B	-7.77B	-7.45B	-7.59B
Common & Preferred Stock Dividends Paid	-7.45B	-7.7B	-7.77B	-7.45B	-7.59B
Other Financing Activities, Total	-1.03B	-157M	-1.29B	-1.47B	-951M
Cash from Financing	-14.17B	-9.67B	-13.11B	-16.28B	-4.24B
Foreign Exchange Rate Adjustments	-184M	-181M	-193M	-463M	-828M
Net Change in Cash	-606M	-348M	1.12B	-1.86B	385M
Supplemental Items
Cash Interest Paid	624M	422M	405M	557M	770M
Cash Income Tax Paid (Refund)	3.54B	3.24B	3.34B	4.1B	3.62B
Levered Free Cash Flow	13.91B	8.42B	12.89B	11.32B	8.6B
Unlevered Free Cash Flow	14.28B	8.68B	13.1B	11.69B	9.11B
Change In Net Working Capital	-1.5B	2.21B	116M	1.58B	1.64B
Net Debt Issued / Repaid	-4.78B	290M	16.35B	-6.1B	5.45B